RESUMO O imatinibe, um inibidor da atividade da tirosina-quinase da proteína BCR-ABL, faz parte do padrão de tratamento para leucemia mieloide crônica (LMC). Por conta de seu efeito imunomodulador, o imatinibe afeta a função dos linfócitos T de várias maneiras ao inibir a sua ativação e proliferação induzidas por antígenos. Linfócitos T e macrófagos antígeno-específicos são vitais para a proteção contra o Mycobacterium tuberculosis. O presente artigo relata um caso de tuberculose renal associada a terapia com imatinibe na fase de manutenção da LMC. Com nefrite intersticial granulomatosa e positividade para DNA de M. tuberculosis na biópsia renal, o paciente foi tratado com sucesso com terapia antituberculínica. O presente caso corrobora a hipótese de que a terapia com imatinibe na LMC aumenta a suscetibilidade à tuberculose, exigindo vigilância rigorosa para permitir sua detecção e tratamento precoces.

ABSTRACT Imatinib, which inhibits tyrosine kinase activity of Bcr-Abl protein, is a standard form of treatment for chronic myeloid leukemia (CML). Through its immunomodulatory effect it affects T cell function in a number of ways. It inhibits antigen-induced T cell activation and proliferation. Antigen-specific T-cells and macrophages are vital for protection against Mycobacterium tuberculosis. Here we present a case of renal tuberculosis associated with imatinib therapy in the maintenance phase of CML. With granulomatous interstitial nephritis and positive tubercular DNA on renal biopsy, the condition was successfully treated with anti-tubercular therapy. This case provides support to the hypothesis that imatinib therapy in CML increases the susceptibility to tuberculosis and strict vigilance is required to enable its early detection and treatment.

Biolixiviação de cobre (0,3%) de um minério de calcopirita de baixo teor, extraído em minas de Malanjkhand, usando um isolador mesofílico nativo, predominante Acidithiobacillus ferrooxidans (A.ferrooxidans), é apresentada. Uma biorrecuperação de 72% Cu foi registrada na presença dessa cultura (não adaptada), que aumentou para 75% com a cultura do minério adaptado e cultivado por 35 dias ao 35ºC e pH 2,0, com <50um partículas. Os dados cinemáticos mostraram mais adequados para o modelo básico de encolhimento controlado por difusão, exibindo lotes lineares de [1- 2/3X- (1-X)2/3] vs temp (X - fração lixiviada). Parece que o papel da bactéria, no processo, é o de converter o íon ferroso para o estado férrico, que oxida a calcopirita para poder dissolver o cobre, mantendo o alto potencial redoxante. O valor da energia de ativação (E) foi calculado em 96 e 108 kJ/mol, para as culturas sem e com adaptação, respectivamente, com temperaturas entre 25-35ºC. Esse mecanismo de lixiviação foi corroborado por identificação fásica XR D e em estudos da resídua da lixiviação.

Bio-leaching of copper (0.3%) from a low grade Indian chalcopyrite ore of Malanjkhand copper mines, using a native mesophilic isolate predominantly Acidithiobacillus ferrooxidans (A.ferrooxidans), is reported. A bio-recovery of 72% Cu was recorded in the presence of this culture (not adapted), which increased to 75% with an ore adapted culture after 35 days at 35ºC and pH 2.0 with <50fim particles. The kinetic data showed best fit for the diffusion-controlled shrinking core model, exhibiting linear plots for [1- 2/3X-(1-X)2/3] vs time (X-fraction leached). Apparently, the role of the bacteria is to convert the ferrous ion to the ferric state, which oxidizes the chalcopyrite in order to dissolve copper, while maintaining a high redox potential. The activation energy value (E) was calculated to be 96 and 108 kJ/mol for the un-adapted culture and the ore adapted culture respectively in the temperature range 25-35ºC. This leaching mechanism was corroborated by XRD phase identification and SEM studies of the leach residue.

The worldwide spread of H5N1 avian influenza has raised concerns that this virus might acquire the ability to pass readily among humans and cause a pandemic.Two anti-influenza drugs currently being used to treat the infected patients are oseltamivir (Tamiflu) and zanamivir (Relenza), both of which target the neuraminidase enzyme of the virus. Reports of the emergence of drug resistance has made the development of new anti-influenza molecules a priority. Various compounds present in Stemona tuberosa a plant belonging to Stemonaceae family was tested for activity against H5N1 neuraminidase. Eight one molecules including stilbenoids, bibenzyls and various others were selected as probable compounds for lead molecules. These lead molecules were tested for toxicity tests and Lipinski rule in Pre ADMET server. Around 33 compounds cleared all these tests. Validated ligand molecules were docked against H5NI Neuraminidase active site residues using AUTODOCK 4 which showed better results in comparison with zanamivir and oseltamivir, anti- influenza drugs.

In this work, modelling of Neuraminidase protein of Influenza A virus (A/Himeji/1/2009(H1N1)) neuraminidase (NA) protein was done using Modeller 9V2. Modelled structure was submitted to protein model database and could be downloaded using accession number PM0075830. The modelled protein structure was subjected to In silco analysis using various bioinformatics tools. Two anti-influenza drugs currently being used to treat infected patients are oseltamivir (Tamiflu) and zanamivir (Relenza), both of which target the neuraminidase enzyme of the virus. Reports of the emergence of drug resistance make the development of new anti-influenza molecules a priority. Hence the modelled structure of H1NI Neuraminidase could be very useful for in silico analysis of potential neuraminidase inhibitors.